News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Hear from some of the world’s leading below the belt researchers and patients through ANZUP’s…
By monitoring early-response biomarkers in men undergoing 177Lu-PSMA prostate cancer treatment, physicians can personalise dosing intervals,…
A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumour uptake, sustained…
Since its introduction in 2015, a prediction tool developed by the European Society of Medical…
Genetic counselling is essential when dealing with individuals who are affected by, or at risk…
Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives…
The Menarini Group (“Menarini”), announced important new data on selinexor at the European Hematology Association (EHA) Congress 2023.…
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as…
Updated dose expansion data of the phase I STRO-002-GM1 study were presented today by Ana Oaknin, Principal…
Ciltacabtagene autoleucel, a BCMA-targeting CAR T-cell therapy, significantly slows or stops progression of multiple myeloma…